VALUE-BASED PRICING SCHEME FOR NEW TECHNOLOGY IN CONSIDERATION OF COST-EFFECTIVENESS DOMINANCE TO THE CONTROL

Author(s)

Kamae I1, Sugimoto T1, Yamabe K2
1The University of Tokyo, Graduate School of Public Policy, Tokyo, Japan, 2Takeda Pharmaceutical Company Ltd., and The University of Tokyo, Tokyo, Japan

OBJECTIVES: This study aims to develop a theoretical scheme to achieve value-based pricing in consideration of the efficiency with respect to the cost-effectiveness dominance of a new technology, compared to the best control or the next best one.

METHODS: Suppose that a pair of cost and benefit of a new technology, the best control and next best one is respectively represented as three points with X(Ex, Cx), S(Es, Cs) and S'(Es', Cs') on the cost-effectiveness plane, assuming the inequalities Es' < Es < Ex and Cs' < Cs < Cx

Conference/Value in Health Info

2015-11, ISPOR Europe 2015, Milan, Italy

Value in Health, Vol. 18, No. 7 (November 2015)

Code

PRM280

Topic

Methodological & Statistical Research

Topic Subcategory

Confounding, Selection Bias Correction, Causal Inference

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×